Adams Joshua D, Garcia Lleowell M, Kern John A
Department of Radiology, University of Virginia Health System, PO Box 800170, Charlottesville, VA 22908, USA.
Surg Clin North Am. 2009 Aug;89(4):895-912, ix. doi: 10.1016/j.suc.2009.06.003.
The use of endovascular stent grafts for treatment of the descending thoracic aorta is reviewed. Currently, 3 devices have been approved by the US Food and Drug Administration for the treatment of descending thoracic aneurysms, and multiple studies are ongoing to investigate the efficacy of endovascular treatment in such pathologies as traumatic aortic injury and Stanford type B dissection. Outcomes are highly dependent on good case planning and patient selection and will likely continue to improve as newer-generation devices and delivery systems are designed and made available.
本文综述了血管内支架移植物在降主动脉治疗中的应用。目前，已有3种器械获得美国食品药品监督管理局批准用于治疗降胸主动脉瘤，并且正在进行多项研究以调查血管内治疗在诸如创伤性主动脉损伤和斯坦福B型夹层等病症中的疗效。治疗结果高度依赖于良好的病例规划和患者选择，并且随着新一代器械和输送系统的设计和应用，结果可能会持续改善。
